![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Breast Cancer |
Free Subscription
6 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Cost-Effectiveness of Breast Cancer Staging Modalities: Counterpoint-Breast MRI
Can be Cost-Effective for Breast Cancer Staging, Particularly in This Era of
Treatment De-Escalation.
AJR Am J Roentgenol. 2023 Apr 26. doi: 10.2214/AJR.23.29501.
PubMed
Cost-Effectiveness of Breast Cancer Staging Modalities: Point-Contrast-Enhanced
Mammography as an Alternative to Breast MRI for Preoperative Staging in Patients
with Breast Cancer.
AJR Am J Roentgenol. 2023 Apr 26. doi: 10.2214/AJR.23.29337.
PubMed
Editorial Comment: Abbreviated MRI for Breast Cancer Neoadjuvant Chemotherapy
Response Assessment-One Step Forward in an Important Research Pathway.
AJR Am J Roentgenol. 2023 Feb 22:9. doi: 10.2214/AJR.23.29167.
PubMed
Frequency and Outcomes of BI-RADS Category 3 Assessments in Patients With a
Personal History of Breast Cancer: Full-Field Digital Mammography Versus Digital
Breast Tomosynthesis.
AJR Am J Roentgenol. 2023 Apr 12. doi: 10.2214/AJR.23.29067.
PubMed
Abstract available
Optoacoustic Imaging With Decision Support for Differentiation of Benign and
Malignant Breast Masses: A 15-Reader Retrospective Study.
AJR Am J Roentgenol. 2022 Dec 7. doi: 10.2214/AJR.22.28470.
PubMed
Abstract available
Beyond the AJR: Racial and Ethnic Disparities in the Timeliness of Biopsy After
Abnormal Screening Mammography.
AJR Am J Roentgenol. 2022 Sep 7. doi: 10.2214/AJR.22.28458.
PubMed
Anti-cancer Effect of Unique Cartilage Matrix-associated Protein in Breast Cancer
Cells Depends on gamma-Carboxylation.
Anticancer Res. 2023;43:1959-1965.
PubMed
Abstract available
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors.
Anticancer Res. 2023;43:1973-1980.
PubMed
Abstract available
Epithelial-mesenchymal Transition Factor and Its Association With Mammographic
Density and Breast Cancer Prognosis.
Anticancer Res. 2023;43:2281-2292.
PubMed
Abstract available
Vacuum-assisted Evacuation (VAEv) of Symptomatic and/or Voluminous Breast
Haematomas Following Surgeries and Percutaneous Procedures.
Anticancer Res. 2023;43:2135-2143.
PubMed
Abstract available
Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic
Tissues in Patients With Breast Cancer.
Anticancer Res. 2023;43:2145-2154.
PubMed
Abstract available
Breast Cancer and SARS-Cov2: Lessons from a Pandemic.
Anticancer Res. 2023;43:2235-2241.
PubMed
Abstract available
Helical Tomotherapy of Lymph Node-negative Early-stage Breast Cancer After
Breast-conserving Surgery: Long-term Results.
Anticancer Res. 2023;43:2041-2053.
PubMed
Abstract available
Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer:
Case Report and Literature Review.
Anticancer Res. 2023;43:2371-2377.
PubMed
Abstract available
CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for
Uterine Cervical Squamous Cell Carcinoma.
Anticancer Res. 2023;43:2077-2084.
PubMed
Abstract available
Clinicopathological Significance and Predictive Value of High Intratumoral Tumor
Budding in Patients With Breast Carcinoma Treated With Neoadjuvant Chemotherapy.
Anticancer Res. 2023;43:2323-2332.
PubMed
Abstract available
Reducing the Use of Frozen Section for Sentinel Node Biopsy in Breast Carcinoma:
Feasibility and Outcome.
Anticancer Res. 2023;43:2161-2170.
PubMed
Abstract available
Meta-analysis of Osteopontin splice variants in cancer.
BMC Cancer. 2023;23:373.
PubMed
Abstract available
High leukocyte mitochondrial DNA copy number contributes to poor prognosis in
breast cancer patients.
BMC Cancer. 2023;23:377.
PubMed
Abstract available
The impact of PIK3CA mutations and PTEN expression on the effect of neoadjuvant
therapy for postmenopausal luminal breast cancer patients.
BMC Cancer. 2023;23:384.
PubMed
Abstract available
SNRPD1 conveys prognostic value on breast cancer survival and is required for
anthracycline sensitivity.
BMC Cancer. 2023;23:376.
PubMed
Abstract available
An exploratory cross-sectional study of the effects of ongoing relationships with
accompanying patients on cancer care experience, self-efficacy, and psychological
distress.
BMC Cancer. 2023;23:369.
PubMed
Abstract available
Functional analyses of rare germline BRCA1 variants by transcriptional activation
and homologous recombination repair assays.
BMC Cancer. 2023;23:368.
PubMed
Abstract available
Age and sex can predict cancer risk in people referred with breast symptoms.
BMJ. 2023;381:e073269.
PubMed
Correction To: Quantifying the effects of risk-stratified breast cancer screening
when delivered in real time as routine practice versus usual screening: the
BC-Predict non-randomised controlled study (NCT04359420).
Br J Cancer. 2023 Apr 24. doi: 10.1038/s41416-023-02273.
PubMed
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.
Br J Cancer. 2023 Apr 24. doi: 10.1038/s41416-023-02272.
PubMed
Abstract available
Alternative methods to measure breast density in younger women.
Br J Cancer. 2023;128:1701-1709.
PubMed
Abstract available
Comparative analysis of EpCAM high-expressing and low-expressing circulating
tumour cells with regard to their clonal relationship and clinical value.
Br J Cancer. 2023;128:1742-1752.
PubMed
Abstract available
Correction: Programmed death ligand 1-positive immune cells in primary tumor or
metastatic axillary lymph nodes can predict prognosis of triple-negative breast
cancer even when present at < 1% in the tumor region.
Breast Cancer. 2023 Apr 27. doi: 10.1007/s12282-023-01454.
PubMed
Options of locoregional therapy for primary foci of breast cancer influence the
rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER
database analysis.
Breast Cancer. 2023 Apr 27. doi: 10.1007/s12282-023-01459.
PubMed
Abstract available
HER2-low-positive and response to NACT and prognosis in HER2-negative
non-metastatic BC.
Breast Cancer. 2023;30:364-378.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Breast Cancer Awareness Among Medical Students, University of Bisha, Saudi
Arabia.
Breast Cancer (Dove Med Press). 2023;15:271-279.
PubMed
Abstract available
Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A
Review.
Breast Cancer (Dove Med Press). 2023;15:281-294.
PubMed
Abstract available
Modifiable risk factors in women at high risk of breast cancer: a systematic
review.
Breast Cancer Res. 2023;25:45.
PubMed
Abstract available
National and subnational burden of female and male breast cancer and risk factors
in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019.
Breast Cancer Res. 2023;25:47.
PubMed
Abstract available
Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an
assessor-participant blinded, randomized, sham-controlled trial.
Breast Cancer Res. 2023;25:49.
PubMed
Abstract available
TP53 somatic mutations in Asian breast cancer are associated with
subtype-specific effects.
Breast Cancer Res. 2023;25:48.
PubMed
Abstract available
Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote
immune infiltration, decelerate tumor growth, and improve survival in
ErbB2/HER2-enriched breast cancer.
Breast Cancer Res. 2023;25:46.
PubMed
Abstract available
Advances in the prevention and treatment of breast cancer-related lymphedema.
Breast Cancer Res Treat. 2023 Apr 27. doi: 10.1007/s10549-023-06947.
PubMed
Abstract available
Feasibility of introducing a smartphone navigation application into the care of
breast cancer patients (The FIONA Study).
Breast Cancer Res Treat. 2023 Apr 27. doi: 10.1007/s10549-023-06918.
PubMed
Abstract available
Use of imaging prediction model for omission of axillary surgery in early-stage
breast cancer patients.
Breast Cancer Res Treat. 2023 Apr 25. doi: 10.1007/s10549-023-06952.
PubMed
Abstract available
Differences in survivorship care experiences among older breast cancer survivors
by clinical cancer characteristics, race/ethnicity, and socioeconomic factors: A
SEER-CAHPS study.
Breast Cancer Res Treat. 2023 Apr 24. doi: 10.1007/s10549-023-06948.
PubMed
Abstract available
Subjective social status, race, and metabolic syndrome in women with breast
cancer.
Breast Cancer Res Treat. 2023 Apr 23. doi: 10.1007/s10549-023-06949.
PubMed
Abstract available
The association between age at breast cancer diagnosis and prevalence of
pathogenic variants.
Breast Cancer Res Treat. 2023 Apr 21. doi: 10.1007/s10549-023-06946.
PubMed
Abstract available
Identification of genetic and immune signatures for the recurrence of
HER2-positive breast cancer after trastuzumab-based treatment.
Breast Cancer Res Treat. 2023 Apr 21. doi: 10.1007/s10549-023-06931.
PubMed
Abstract available
Increased survival of women with luminal breast cancer and progesterone receptor
immunohistochemical expression of greater than 10.
Cancer. 2023 Apr 27. doi: 10.1002/cncr.34828.
PubMed
Reply to "Increased survival of women with luminal breast cancer and progesterone
receptor immunohistochemical expression of greater than 10%".
Cancer. 2023 Apr 27. doi: 10.1002/cncr.34826.
PubMed
Plasma levels of interleukin-6 mediate neurocognitive performance in older breast
cancer survivors: The Thinking and Living With Cancer study.
Cancer. 2023 Apr 25. doi: 10.1002/cncr.34784.
PubMed
Abstract available
Neighborhood attributes and cardiovascular disease risk in breast cancer
survivors: The Pathways Study.
Cancer. 2023 Apr 25. doi: 10.1002/cncr.34794.
PubMed
Abstract available
Understanding the role of access in Hispanic cancer screening disparities.
Cancer. 2023;129:1569-1578.
PubMed
Abstract available
Is repeat sentinel lymph node biopsy possible for surgical axillary staging among
patients with ipsilateral breast tumor recurrence?
Cancer. 2023;129:1492-1501.
PubMed
Abstract available
Association between major discrimination and deficit accumulation in African
American cancer survivors: The Detroit Research on Cancer Survivors Study.
Cancer. 2023;129:1557-1568.
PubMed
Abstract available
Surgical-Site Infection is Associated With Increased Risk of Breast
Cancer-Related Lymphedema: A Nationwide Cohort Study.
Clin Breast Cancer. 2023 Apr 5:S1526-8209(23)00085.
PubMed
Abstract available
The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on
Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study.
Clin Breast Cancer. 2023 Mar 22:S1526-8209(23)00075.
PubMed
Abstract available
Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in
Metastatic Breast Cancer With Low HER2 Expression.
Clin Breast Cancer. 2023 Mar 31:S1526-8209(23)00082.
PubMed
Abstract available
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in
patients with treatment refractory HER-2/neu overexpressing breast cancer.
Clin Cancer Res. 2023 Apr 24:CCR-22-3578. doi: 10.1158/1078-0432.CCR-22-3578.
PubMed
Abstract available
Clonal Hematopoiesis in Young Women Treated for Breast Cancer.
Clin Cancer Res. 2023 Apr 28:CCR-23-0050. doi: 10.1158/1078-0432.CCR-23-0050.
PubMed
Abstract available
The value of case reports in rare oncological scenarios: mixed method analysis of
colorectal metastases from breast cancer.
Clin Exp Metastasis. 2023 Apr 27. doi: 10.1007/s10585-023-10207.
PubMed
Abstract available
Correlation of NNMT and DKK1 Protein Expression With Clinicopathological
Characteristics and Prognosis of Breast Cancer.
Clin Med Insights Oncol. 2023;17:11795549231168073.
PubMed
Abstract available
Evaluation of predictive and prognostic value of androgen receptor expression in
breast cancer subtypes treated with neoadjuvant chemotherapy.
Discov Oncol. 2023;14:49.
PubMed
Abstract available
Spatiotemporal higher-order chromatin landscape of human histone gene clusters at
Histone Locus Bodies during the cell cycle in breast cancer progression.
Gene. 2023 Apr 22:147441. doi: 10.1016/j.gene.2023.147441.
PubMed
Abstract available
Nanoparticle drug delivery to target breast cancer brain metastasis: Current and
future trends.
Int J Cancer. 2023 Apr 25. doi: 10.1002/ijc.34542.
PubMed
Abstract available
Impact of Artificial Intelligence System and Volumetric Density on Risk
Prediction of Interval, Screen-Detected, and Advanced Breast Cancer.
J Clin Oncol. 2023 Apr 27:JCO2201153. doi: 10.1200/JCO.22.01153.
PubMed
Abstract available
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in
High-Risk Early Breast Cancer.
J Clin Oncol. 2023 Apr 27:JCO2300615. doi: 10.1200/JCO.23.00615.
PubMed
Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for
sentinel lymph node biopsy?
J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27231.
PubMed
Abstract available
Increasing rates of general anesthesia use in lumpectomy procedures: A 15-year
trends analysis.
J Surg Oncol. 2023;127:1092-1102.
PubMed
Abstract available
Advancing outcomes of metastatic HER2-positive breast cancer.
Lancet. 2023 Apr 19:S0140-6736(23)00805-X. doi: 10.1016/S0140-6736(23)00805.
PubMed
Trastuzumab deruxtecan versus treatment of physician's choice in patients with
HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised,
open-label, multicentre, phase 3 trial.
Lancet. 2023 Apr 19:S0140-6736(23)00725-0. doi: 10.1016/S0140-6736(23)00725.
PubMed
Abstract available
Early Triple-Negative Breast Cancers in a Singapore Cohort Exhibit High PIK3CA
Mutation Rates Associated With Low PD-L1 Expression.
Mod Pathol. 2023;36:100056.
PubMed
Abstract available
The prognostic value and immune microenvironment association of AR in HER2+
nonmetastatic breast cancer.
NPJ Breast Cancer. 2023;9:30.
PubMed
Abstract available
Self-managed physical activity in breast cancer survivors: A scoping review.
PLoS One. 2023;18:e0284807.
PubMed
Abstract available
How many days of continuous physical activity monitoring reliably represent time
in different intensities in cancer survivors.
PLoS One. 2023;18:e0284881.
PubMed
Abstract available
Women's perception about the discovery of breast cancer amid the covid-19
pandemic.
PLoS One. 2023;18:e0282610.
PubMed
Abstract available
Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer
patients: Systematic review and meta-analysis.
PLoS One. 2023;18:e0277714.
PubMed
Abstract available
Mammographic Screening in Routine Practice: Multisite Study of Digital Breast
Tomosynthesis and Digital Mammography Screenings.
Radiology. 2023 Mar 14:221571. doi: 10.1148/radiol.221571.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by